Swell in Off-Label Antipsychotic Prescribing 'Not Harmless'
A growing trend of off-label, low-dose antipsychotic prescribing to treat disorders such as anxiety and insomnia has been tied to an increased risk of cardiometabolic death.
Source: medscape.com